Design of LONGEVITI (LIVinG with chrONIc cancEr Therapies): A Narrative Arts-Based Study of Living with Advanced Cancers Treated with Targeted Therapy

Today, cancer treatments and the resultant illness experience is rapidly changing. In the early 2000’s breakthroughs in cancer biology and technology allowed the detection of molecular tumor characteristics promoting cancer growth, metastasis and cell immortality. These discoveries prompted the development of oral drugs specifically designed to block these targets. These oral targeted medications are ‘cytostatic’ as the disease remains in ‘stasis’ and does not grow or advance. As a result, advanced cancers that were formerly rapid death sentences are now treated with agents so effective that people are living for years with stable advanced cancers. Survivorship is commonly interpreted to define a state of being for individuals cured of early stage or localized cancers, commonly treated with surgery, chemotherapy and/or radiation. For those living with incurable chronic cancer, the cancer ‘battle’ is different from that of curable individuals. Targeted therapies continue until diagnostic imaging or bloodwork demonstrates the cancer is becoming resistant. Accordingly, incurable chronic cancer and evolving physical effects of the disease remain powerfully omnipresent for the remainder of the individual’s life. The aim of this research is to explore the day-to-day experiences of people living with advanced chronic cancers while being treated with self-administered oral targeted therapies. We will collect data through both qualitative interviews and arts-based methods. Semi structured in-depth interviews will explore people’s experiences of living with advanced cancers and receiving targeted therapies. The LIVinG with chrONIc cancEr treatments (LONGEVITI) study will enhance our understanding of the experiences of individuals self-managing advanced cancer with targeted medications. It will also assess the acceptability of innovative research methodologies. Ultimately, the goal is to advanced knowledge about this new and complex chronic disease among patients, healthcare providers and the general public.

• Publication year

  2025

• Venue

  International Journal of Qualitative Methods

• Publication date

  2025-08-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1177/16094069251376201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-World Treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic Breast Cancer in a Canadian Setting Using AI-Extracted Data

  2024cited by this paper
• The impact of prehabilitation on outcomes in frail and high-risk patients undergoing major abdominal surgery: A systematic review and meta-analysis.

  2024cited by this paper
• Cancer Care Team Functioning during COVID-19: A Narrative Literature Review and Synthesis

  2024cited by this paper
• Virtual Cancer Care Beyond the COVID-19 Pandemic: Patient and Staff Perspectives and Recommendations

  2024cited by this paper
• The rhythms of cancer survivorship

  2022cited by this paper
• Hallmarks of Cancer: New Dimensions.

  2022cited by this paper
• Still Lost in Transition? Perspectives of Ongoing Cancer Survivorship Care Needs from Comprehensive Cancer Control Programs, Survivors, and Health Care Providers

  2022cited by this paper
• Cancer as a new chronic disease: Oncology nursing in the 21st Century.

  2022influential reference
• To ring or not to ring: An interpretive description of cancer patients and caregivers exiting treatment.

  2020cited by this paper
• MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

  2019cited by this paper
• The Unsayable in Arts-Based Research: On the Praxis of Life Itself

  2019cited by this paper
• Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

  2019cited by this paper
• The wounded storyteller

  2018cited by this paper
• The Wounded Storyteller Body Illness And Ethics

  2016cited by this paper
• What Difference Can "Experience" Make to Pragmatism?

  2014cited by this paper
• The unsayable: a concept analysis.

  2013cited by this paper
• Targeted therapy for metastatic renal cell carcinoma: Current treatment and future directions

  2013cited by this paper
• Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.

  2011cited by this paper
• Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions

  2010cited by this paper
• Narrative Knowing and the Human Sciences

  2010cited by this paper
• Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support

  2009cited by this paper
• Memoing in qualitative research

  2008cited by this paper
• Narrative Inquiry: A Methodology for Studying Lived Experience

  2006cited by this paper
• Qualitative research sampling: the very real complexities.

  2004cited by this paper
• Two Decades of Developments in Qualitative Inquiry

  2002cited by this paper
• An overview of three different approaches to the interpretation of qualitative data. Part 1: Theoretical issues.

  2002cited by this paper
• Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries?

  1997cited by this paper
• Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge.

  1997cited by this paper

• No citing papers are available for this paper.